发明名称 |
TREATMENT REGIMEN UTILIZING NERATINIB FOR BREAST CANCER |
摘要 |
The invention provides neratinib for use in a method for treating early stage HER-2 positive breast cancer, wherein the method comprises delivering neratinib therapy to early stage HER-2 positive breast cancer patients at the completion of at least twelve months of trastuzumab adjuvant therapy; wherein the neratinib therapy is started about 2 weeks to about one year from the completion of surgical and standard adjuvant therapy. |
申请公布号 |
EP2416774(B1) |
申请公布日期 |
2015.11.04 |
申请号 |
EP20100722215 |
申请日期 |
2010.03.24 |
申请人 |
WYETH LLC |
发明人 |
BERKENBLIT, ANNA;BINLICH, FLORENCE;GOSS, PAUL |
分类号 |
A61K31/4709;A61P35/00 |
主分类号 |
A61K31/4709 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|